Enhanced Control of Hypertension and Thrombolysis in Stroke Study (STAY ENCHANTED)

在中风研究中加强高血压和溶栓控制（STAY ENCHANTED）

• 批准号: nhmrc : 1101113
• 负责人: Prof Hisatomi Arima
• 金额: $ 166.87万
• 依托单位: Australian National University
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2016
• 资助国家: 澳大利亚
• 起止时间: 2016-01-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/enhanced-control-hypertension-stay-enchanted/662539
• 关键词: Enhanced; Control; Hypertension; Thrombolysis; Stroke

"Clot busting" treatment is the only approved medical treatment for the commonest type of stroke, ischaemic stroke. However, uptake of treatment remains poor, mainly due to the known major risk of bleeding in the brain. STAY ENCHANTED is an international clinical trial to investigate whether "clot-busting" can be made safer using a lower dose and/or immediate blood pressure lowering. A safer more effective regime could have a major global health impact.

“凝块破坏”治疗是唯一被批准用于最常见的中风类型--缺血性中风的医学治疗。然而，治疗的吸收仍然很差，主要是由于已知的脑出血的主要风险。STAY ENCHANTED是一项国际临床试验，旨在研究使用较低剂量和/或立即降低血压是否可以使“血栓破裂”更安全。一个更安全、更有效的制度可以对全球健康产生重大影响。